Response to Letter Regarding Article, “Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial”
Author(s) -
Richard G. Bach,
Maria M. Brooks,
M. Lombardero,
Saul Genuth,
Thomas Donner,
Alan J. Garber,
Laurence Kennedy,
E. Scott Monrad,
Rodica PopBusui,
Sheryl F. Kelsey,
Robert L. Frye
Publication year - 2014
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.113.008033
Subject(s) - medicine , rosiglitazone , diabetes mellitus , angioplasty , coronary artery disease , revascularization , cardiology , disease , coronary artery bypass surgery , artery , myocardial infarction , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom